Earnings Outlook For Xenon Pharmaceuticals
Portfolio Pulse from Benzinga Insights
Xenon Pharmaceuticals (NASDAQ:XENE) is scheduled to release its quarterly earnings report on Thursday, 2024-02-29, with analysts expecting an EPS of $-0.76. The company's past earnings performance shows a mixed impact on its stock price, with the last quarter's beat resulting in a 6.69% drop. Shares have risen 31.62% over the last 52 weeks, indicating a positive long-term outlook. Investors will be keen on both the earnings outcome and the company's future guidance.
February 28, 2024 | 3:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Xenon Pharmaceuticals is expected to announce its quarterly earnings with an anticipated EPS of $-0.76. Historical data shows mixed reactions to past earnings, with a notable 6.69% drop after the last beat. The stock has seen a 31.62% increase over the past year, indicating a positive trend.
Given the mixed historical stock price reactions to earnings announcements, it's challenging to predict the short-term impact of the upcoming earnings report. However, the positive yearly stock performance and anticipation around beating the EPS estimate could maintain investor interest and potentially support the stock price.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100